These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31315475)

  • 1. Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain Mutation.
    Zaleta-Rivera K; Dainis A; Ribeiro AJS; Cordero P; Rubio G; Shang C; Liu J; Finsterbach T; Parikh VN; Sutton S; Seo K; Sinha N; Jain N; Huang Y; Hajjar RJ; Kay MA; Szczesna-Cordary D; Pruitt BL; Wheeler MT; Ashley EA
    Circulation; 2019 Aug; 140(9):765-778. PubMed ID: 31315475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
    Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
    Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM.
    Yadav S; Yuan CC; Kazmierczak K; Liang J; Huang W; Takeuchi LM; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    J Mol Med (Berl); 2019 Jul; 97(7):1033-1047. PubMed ID: 31101927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin.
    Hitsumoto T; Tsukamoto O; Matsuoka K; Li J; Liu L; Kuramoto Y; Higo S; Ogawa S; Fujino N; Yoshida S; Kioka H; Kato H; Hakui H; Saito Y; Okamoto C; Inoue H; Hyejin J; Ueda K; Segawa T; Nishimura S; Asano Y; Asanuma H; Tani A; Imamura R; Komagawa S; Kanai T; Takamura M; Sakata Y; Kitakaze M; Haruta JI; Takashima S
    Circulation; 2023 Jun; 147(25):1902-1918. PubMed ID: 37128901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
    J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
    Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
    FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.
    Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D
    FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy.
    Huang J; Shelton JM; Richardson JA; Kamm KE; Stull JT
    J Biol Chem; 2008 Jul; 283(28):19748-56. PubMed ID: 18474588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.
    Yadav S; Sitbon YH; Kazmierczak K; Szczesna-Cordary D
    Pflugers Arch; 2019 May; 471(5):683-699. PubMed ID: 30706179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
    Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
    FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo.
    Chang AN; Battiprolu PK; Cowley PM; Chen G; Gerard RD; Pinto JR; Hill JA; Baker AJ; Kamm KE; Stull JT
    J Biol Chem; 2015 Apr; 290(17):10703-16. PubMed ID: 25733667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified
    Yuan CC; Kazmierczak K; Liang J; Zhou Z; Yadav S; Gomes AV; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2338-E2347. PubMed ID: 29463717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
    Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
    Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.